DJ Inovio Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ shed 7.86% to $5.39 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 2.23% to 15,164.01 and Dow Jones Industrial Average falling 0.82% to 38,150.30.
This was the stock's second consecutive day of losses.
Inovio Pharmaceuticals Inc. closed $18.01 below its 52-week high ($23.40), which the company reached on February 3rd.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ rose 0.08% to $158.90, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ rose 0.22% to $27.08.
Trading volume (671,404) eclipsed its 50-day average volume of 354,101.
Data source: Dow Jones Market Data, FactSet. Data compiled January 31, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 31, 2024 17:31 ET (22:31 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments